日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Efficacy of Brexpiprazole in Participants with Agitation Associated with Dementia Due to Alzheimer's Disease: Pooled Analysis of Randomized Controlled Trials

Brexpiprazole治疗阿尔茨海默病痴呆相关躁动患者的疗效：随机对照试验的汇总分析

期刊:Clinical Drug Investigation
影响因子:2.7
doi:10.1007/s40261-025-01517-9
Cummings, Jeffrey L; Chumki, Sanjeda R; Chang, Denise; Zhang, Zhen; Brubaker, Malaak; Hefting, Nanco; Such, Pedro; Wang, David; Grossberg, George T
阿尔茨海默症
发表日期：2026
文献求助 收藏

Addressing Unmet Medical Needs in Drug Development: Assessment and Implications for Regulatory and Clinical Development Strategies

药物研发中未满足的医疗需求：评估及其对监管和临床开发策略的影响

期刊:Journal of Market Access Health Policy
影响因子:
doi:10.3390/jmahp14010015
Domingo-Esteban, Carla; Heikkinen, Inka; Hefting, Nanco
发表日期：2026
文献求助 收藏

Brexpiprazole and Sertraline Combination Treatment in Posttraumatic Stress Disorder: A Phase 3 Randomized Clinical Trial

Brexpiprazole 和 Sertraline 联合治疗创伤后应激障碍：一项 3 期随机临床试验

期刊:JAMA Psychiatry
影响因子:17.1
doi:10.1001/jamapsychiatry.2024.3996
Davis, Lori L; Behl, Saloni; Lee, Daniel; Zeng, Hui; Skubiak, Taisa; Weaver, Shelley; Hefting, Nanco; Larsen, Klaus Groes; Hobart, Mary
创伤后应激障碍
神经科学
发表日期：2025
文献求助 收藏

Safety and Tolerability of Brexpiprazole in Participants with Agitation Associated with Dementia due to Alzheimer's Disease: Pooled Analysis of Three Randomized Trials and an Extension Trial

Brexpiprazole治疗阿尔茨海默病痴呆相关躁动患者的安全性和耐受性：三项随机试验和一项扩展试验的汇总分析

期刊:CNS Drugs
影响因子:7.4
doi:10.1007/s40263-025-01200-9
Shah, Alpesh; Estilo, Alvin; Sheridan, Pamela L; Kalu, Uwa; Chen, Dalei; Chang, Denise; Slomkowski, Mary; Lee, Daniel; Hefting, Nanco; Hobart, Mary; Behl, Saloni; Such, Pedro; Brubaker, Malaak; Grossberg, George T
阿尔茨海默症
发表日期：2025
文献求助 收藏

Fixed-Dose Brexpiprazole and Sertraline Combination Therapy for the Treatment of Posttraumatic Stress Disorder: A Phase 3, Randomized Trial

固定剂量布瑞哌唑和舍曲林联合疗法治疗创伤后应激障碍：一项3期随机试验

期刊:Journal of Clinical Psychopharmacology
影响因子:2.8
doi:10.1097/JCP.0000000000002076
Davis, Lori L; Behl, Saloni; Lee, Daniel; Zeng, Hui; Skubiak, Taisa; Weaver, Shelley; Hefting, Nanco; Larsen, Klaus Groes; Hobart, Mary
创伤后应激障碍
神经科学
发表日期：2025
文献求助 收藏

Family physicians' attitudes and practice on screening and prevention of fragility fractures, and shared decision-making with postmenopausal women: a qualitative study in Spain

家庭医生对脆性骨折筛查和预防的态度和实践，以及与绝经后妇女的共同决策：一项西班牙的定性研究

期刊:BMC Primary Care
影响因子:2.6
doi:10.1186/s12875-025-02966-z
León-García, Montserrat; Martínez, Esther Cánovas; Pérez, Yolanda Álvarez; Pou, María Antonia; García-Franco, Alberto López; Bas, Ana Sanz; Rodriguez-Moreno, Sara; Espinoza, Claudia Erika Delgado; Roca, Pablo; Osuna, Aránzazu González; Valverde, Diana Fernández; Nanco, Betzabeth Marín; Medina-Aedo, Melixa; Perestelo-Pérez, Lilisbeth; Alonso-Coello, Pablo
骨折
发表日期：2025
文献求助 收藏

Safety and Tolerability of Brexpiprazole in Adolescents With Schizophrenia: A Long-Term, Open-Label Study

Brexpiprazole在青少年精神分裂症患者中的安全性和耐受性：一项长期开放标签研究

期刊:
影响因子:
doi:10.1016/j.jaacop.2024.04.005
Atkinson, Sarah D; Shah, Alpesh; Burgess, Maria Victoria; Hefting, Nanco; Chen, Dalei; Ward, Caroline
精神分裂症
神经科学
发表日期：2025
文献求助 收藏

Defining a clinically meaningful within-patient change threshold for the Cohen-Mansfield Agitation Inventory in Alzheimer's dementia

确定阿尔茨海默病痴呆症患者科恩-曼斯菲尔德躁动量表具有临床意义的患者内变化阈值

期刊:Frontiers in Neurology
影响因子:2.8
doi:10.3389/fneur.2024.1379062
Meunier, Juliette; Creel, Kristin; Loubert, Angély; Larsen, Klaus Groes; Aggarwal, Jyoti; Hefting, Nanco; Oberdhan, Dorothee
阿尔茨海默症
发表日期：2024
文献求助 收藏

Brexpiprazole for the Treatment of Agitation in Alzheimer Dementia: A Randomized Clinical Trial

布瑞哌唑治疗阿尔茨海默病痴呆症躁动：一项随机临床试验

期刊:Jama Neurology
影响因子:21.3
doi:10.1001/jamaneurol.2023.3810
Lee, Daniel; Slomkowski, Mary; Hefting, Nanco; Chen, Dalei; Larsen, Klaus Groes; Kohegyi, Eva; Hobart, Mary; Cummings, Jeffrey L; Grossberg, George T
阿尔茨海默症
发表日期：2023
文献求助 收藏

Two randomized, double-blind, placebo-controlled trials and one open-label, long-term trial of brexpiprazole for the acute treatment of bipolar mania

两项随机、双盲、安慰剂对照试验和一项开放标签、长期试验，研究了布瑞哌唑治疗双相情感障碍躁狂症急性发作的疗效。

期刊:Journal of Psychopharmacology
影响因子:5.5
doi:10.1177/0269881120985102
Vieta, Eduard; Sachs, Gary; Chang, Denise; Hellsten, Johan; Brewer, Claudette; Peters-Strickland, Timothy; Hefting, Nanco
发表日期：2021
文献求助 收藏